Company Filing History:
Years Active: 2025
Title: Beril Karakas: Innovator in Telomerase Research
Introduction
Beril Karakas is a prominent inventor based in Reno, NV (US). She has made significant contributions to the field of biotechnology, particularly in the area of telomerase research. Her innovative work focuses on enhancing the expression of telomerase reverse transcriptase (TERT), which has important implications for cellular aging and cancer research.
Latest Patents
Karakas holds a patent for "Telomerase reverse transcriptase (TERT) expression enhancing compounds and methods for using the same." This patent includes various azole compounds, such as pyrazoles, imidazoles, triazoles, tetrazoles, thiazoles, isothiazoles, oxazoles, and isoxazoles. In certain embodiments, the azole compound features an acyl substituent, including an amide, such as an alkyl amide. The methods described in her patent involve contacting cells with a TERT expression enhancing effective amount of the compound to increase TERT expression in the cells. These compounds and methods are valuable in applications where increased expression of telomerase reverse transcriptase is desired.
Career Highlights
Karakas is associated with Sierra Sciences, Inc., a company dedicated to advancing research in telomerase and its applications. Her work has positioned her as a key figure in the biotechnology sector, contributing to the understanding of telomerase and its potential benefits.
Collaborations
Some of her notable coworkers include William H. Andrews and Christopher A. Foster, who have also made significant contributions to the field of telomerase research.
Conclusion
Beril Karakas is an influential inventor whose work on TERT expression enhancing compounds is paving the way for advancements in biotechnology. Her contributions are essential for future research and applications in cellular aging and cancer treatment.